Intellectual property rights
- The global politics of pharmaceutical monopoly power
- E.F.M. Hoen / Access to Essential Medicines Campaign, MSF, 2009
- This paper states that many countries were able to use the TRIPS flexibilities to access lower-priced generic drugs. However, as pharmaceutical product patents start to be granted in producing countri...
- Drug patents in French-speaking Africa
- P. Boulet; Gilles-Bernard Forte / Access to Essential Medicines Campaign, MSF, 2000
- This paper summarises the measures included in the original 1977 Bangui Agreement, which established the African Organization for Intellectual Property (OAPI) and regulates patents and IP in 15 west A...
- Responding to market failures in tuberculosis control
- R. Gupta / Access to Essential Medicines Campaign, MSF, 2001
- This report evaluates the success of a programme to negotiate cost reductions in TB drugsThe specter of multidrug-resistant tuberculosis (MDR-TB) threatens the gains achieved by tuberculosis contro...
- Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries (4th Edition)
- C. Perez-Casas; C. Macé; D. Berman; J. Double / Access to Essential Medicines Campaign, MSF, 2003
- The data in this guide on ARV prices offered by originator companies and some generic companies in low- and middle-income countries are meant to provide potential buyers with clear verified data. This...
- Accord Bangui (Bangui Agreement)
- Access to Essential Medicines Campaign, MSF, 1999
- Full text of the original 1977 Bangui Agreement which established the African Organization for Intellectual Property (OAPI) and the 1999 revisions which brought the agreement in line with TRIPS.(In...
- Human resources for health and ART scale-up in sub-Saharan Africa: A background paper for the MSF Access to Essential Drugs Campaign
- K. Kober; W. Van Damme / Access to Essential Medicines Campaign, MSF, 2005
- This report, prepared as a background paper for the MSF Access to Essential Drugs Campaign, examines how the current human resources for health (HRH) situation in sub-Saharan Africa will affect attemp...
- Access to medicines at risk across the globe: what to watch out for in free trade agreements with the United States
- Access to Essential Medicines Campaign, MSF, 2004
- The United States (US) is using bilateral trade agreements to restrict the availability of low-cost medicines to developing countries, according to this briefing paper from Médecins Sans Frontiéres (M...
- Rapid expansion, emerging challenges
- Access to Essential Medicines Campaign, MSF, 2004
- This MSF briefing document describes some of the progress on antiretroviral therapy (ART), as well as some of the emerging operational and clinical challenges. It presents this information from the p...
- Surmounting challenges: procurement of antiretroviral medicines in low- and middle-income countries
- Access to Essential Medicines Campaign, MSF, 2003
- As the price of antiretrovirals (ARVs) in low- and middle-income countries has fallen in recent years, governments, international agencies and non-governmental organisations have been able to start de...
- Demystifying antiretroviral therapy in resource-poor settings
- Access to Essential Medicines Campaign, MSF, 2003
- This paper uses the example of a poor township 30 kilometres outside Cape Town to find out if antiretroviral therapy is possible in severely resource-constrained environments and to discover the best ...
